FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
--------------------------
1934
----
December 27, 2004
Commission File Number 001-14978
SMITH & NEPHEW plc
(Registrant's name)
15 Adam Street
London, England WC2N 6LA
(Address of registrant's principal executive offices)
[Indicate by check mark whether the registrant files or will file
annual reports under cover Form 20-F or Form 40-F.]
Form 20-F X Form 40-F
----- -----
[Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1).]
Yes No X
----- ------
[Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7).]
Yes No X
----- ------
[Indicate by check mark whether by furnishing the information
contained in this Form, the registrant is also thereby furnishing information
to the Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange
Act of 1934.]
Yes No X
----- ------
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2(b): 82- n/a.
---
Total Pages: 4
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Smith & Nephew plc
(Registrant)
Date: December 27, 2004 By: /s/ Paul Chambers
-----------------
Paul Chambers
Company Secretary
2
Smith & Nephew plc T 44 (0) 207 401 7646 [LOGO OMITTED] We are smith&nephew
15 Adam Street F 44 (0) 207 960 2350
London WC2N 6LA www.smith-nephew.com
England
SMITH & NEPHEW ANNOUNCEMENT DATES FOR 2005 AND DETAILS OF THE BRIEFING AT THE
AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
22 December 2004
Smith & Nephew plc (NYSE:SNN; LSE:SN) will announce its preliminary results
for 2004 at 12.00 noon GMT/7.00am EST on 3 February 2005. A presentation for
analysts will be held at 2.00pm GMT/9.00am EST.
The company will announce its quarterly results through the year as follows:
Quarter 1 5 May 2005
Interims/Quarter 2 4 August 2005
Quarter 3 27 October 2005
The company will host a meeting for analysts and investors at the American
Academy of Orthopaedic Surgeons (AAOS), the largest orthopaedic congress in
the world, at 8.00am (EST) on Wednesday 23 February 2005 in Washington DC.
The meeting will be hosted by Sir Christopher O'Donnell, Chief Executive, with
presentations from Dave Illingworth, President of Smith & Nephew's
orthopaedics business, and Jim Taylor, President of the endoscopy business.
The presentations will focus on Smith & Nephew products being exhibited by the
orthopaedic and endoscopy businesses at the surgeon meeting. These will also
be broadcast live by webcast on the Smith & Nephew website at
www.smith-nephew.com and will be available on the site archive shortly
afterwards.
About Us
Smith & Nephew (LSE: SN, NYSE:SNN) is one of the world's leading medical
devices companies, specialising in Orthopaedics, Endoscopy and Advanced Wound
Management. Smith & Nephew ranks as the global leader in arthroscopy and
advanced wound management and is the fastest growing full-line orthopaedics
company in the world.
Smith & Nephew is dedicated to helping improve people's lives. The company
prides itself on the strength of its relationships with its surgeon and
healthcare professional customers, with whom its name is synonymous with the
highest standards of performance, innovation and trust. The company has over
8,000 employees and operates in 32 countries around the world, generating
sales of over (GBP) 1 billion.
News
Enquiries:
UK Smith & Nephew Contact
Peter Nind Tel: +44 (0)20 7401 7646
Corporate Affairs Manager
US Smith & Nephew Contact
Angie Craig Tel: +1 212 850 5756
Vice President US Investor and Media Relations